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Clinical and physiological changes
One of the early pieces of evidence in favor of reduced thyroid hormone action with aging was the finding of reduced basal metabolic rate (BMR) in the elderly (8) .
However, this observation later was found to be independent of thyroid hormone and to be attributed mostly to the age-related decrease in lean body mass (9) . Despite negligible changes in plasma thyroid hormone concentrations, elderly subjects often mani¬ fest a host of clinical signs and symptoms that are reminiscent of hypothyroidism. These manifestations are summarized in Table 1 (5) (6) (7) .
The increased incidence of body weight loss in the hyperthyroid elderly patients can be misinterpreted as an apparent increase in the catabolic effect of thyroid hormone with age. Of interest is that in an animal model of aging where kidney failure and gross tumors were excluded, thyroid hormone administration resulted in a greater degree of body weight loss compared to younger animals ( Fig. 1) (10) . This difference in body weight loss, however, could be ascribed totally to reduced food intake in aged rats.
When differences in food intake were taken into account and young rats pair-fed with aged rats were included as controls, the age-related differences in catabolic effects of thyroid hormone disappeared (10 •^. (26, 27) . However, the studies in the two age groups were not done in parallel and there was some overlap in the ages of subjects within the older group and the young controls (26, 27) . Overall thyroid function is well preserved until advanced age and there is no evidence that alterations in thyroid gland secretions contribute to aging (28) . hormone metabolism and the observed changes were attributed to decreased T4 degradation with age (30) .
Tissue responsiveness to the lipid peroxidationinducing effects of thyroid hormone also may be reduced if one takes into account the altered caloric consumption of aged rats (31) . Thus, the ethane exhalation rate, an index of lipid peroxidation, is reduced in rats with aging. In addition, acutely or chronically T3-treated aged rats have lower ethane (48) . This may partly explain the reduced manifestations of adrenergic overactivity in elderly hyperthyroid patients.
When 12-month-old rats are compared to 2-monthold rats, the hemodynamic consequences of T3 treatment were attenuated in older rats (46) . The decreased sensitivity of chronotropic response to isoproterenol in older rats could be normalized with T3 treatment. These studies clearly indicated that thyroid hormone-induced and age-related changes in /3-adrenergic response are interrelated (46) . (63) . Although most of the change was observed during maturation, there was an additional reduction of approximately 50% in ME activity in 26-month-old rats compared to 6-month-old mature rats (63) (Fig. 3) . In these studies the animals bearing tumors and those with elevated serum creatinine levels were excluded from the analysis in order to minimize disease-related effects in the aging rats. There was a close correlation between response of ME activity and ME mRNA levels to T3 in young and aged rat liver (Fig. 3) .
Pair feeding of young rats with aged rats resulted in an increase rather than a decrease in basal and T3-stimulated ME activity (63 (63) . Thus, there appears to be a net 50% reduction in T3-stimulated ME activity with age in addition to the changes in basal levels. It is noteworthy that in younger age groups up to 18 months of age, the response of ME activity to T3 relative to baseline does not change with age (59) . This suggests that mechanisms of reduced T3 responsiveness associated with maturation are different from those observed in studies of aging animals.
The second line of evidence in favor of reduced ME responsiveness to T3 with age comes from studies of rats fed 60% fructose diets. This diet resulted in increased ME activity in aged rats to the same level as that of young rats fed identical diets, yet T3 responsiveness was still 50% reduced compared to T3-treated young rats fed the same diet (64) (Fig. 4) . Similar trends were found in rats fed 60% dextrose diets. Thirdly, the age-related decrease in T3 responsiveness also is found in the expression of the S14 gene in aged rats. The rat liver S14 gene encodes a small nuclear protein (pi 4.9, Mr 17 010) that is believed to be involved in lipogenesis (65) . The basal levels of S14 mRNA were not detectable in neonatal animals but increased steadily with age. In the adult rat, the levels of this mRNA are roughly 200-fold higher relative to the newborn animals. Further aging is associated with even higher levels (66) . The Sj4 gene has served as a valuable marker of thyroid hormone action in the nucleus because of its rapid induction by T3. In a recent study, thyroid hormone treatment of young euthyroid rats resulted in a 7.6-fold increase in levels of the S14 mRNA, while parallel studies in aged rats (26 months old) yielded a three-to fourfold induction of the gene (67) . Although the overall level of S14 mRNA was higher in aged animals, the induction over the euthyroid level was higher in the young as compared to the older animals. This observation is remarkably similar to the 50% reduction in ME response to T3 with aging. This age-related decline in T3 responsiveness of S14 is evident in a biochemical parameter that, unlike ME, shows an age-related increase in basal expression. Overall evidence, there¬ fore, favors the notion that T3 responsiveness of key biomarkers of thyroid hormone action in the liver is reduced with aging.
The changes that we have described for the ME and S14 genes are specific and do not extend to other thyroid hormone-responsive sequences. For example, the expression of the T3-responsive apolipoprotein A-I (apo -I) gene product is known to decrease with maturation but the responsiveness to T3 may not be altered (68 groups is that the expected reduction in apo -I mRNA observed in young animals during hypothyroidism is not present in the aged group (68) . These changes underscore the spectrum of the age-related changes that may occur in response to thyroid hormone. In the central nervous system (CNS), the expression of pep-2 gene, a purkinje cell-specific gene, is induced by thyroid hormone during the neonatal development. This thyroid hormone responsiveness is lost in the adult animal (69) . These changes were maturational and cannot be extrapolated to the alterations occurring between adulthood and senescence.
Another example of an age-related reduction in the cellular response of the CNS to thyroid hormone is the blunted /3-adrenergic receptor upregulation in the synaptosomal membranes of aged rats (24 months old) in response to exogenous T3 administration (70) . The adenylyl cyclase activity response to prostaglandin also was reduced in synaptosomal membranes of aged rats. Thyroid hormone did not induce the activity of this enzyme either in young or aged rats (70) .
Overall, it appears that aging is associated with altered thyroid hormone effects on several key cellular markers of thyroid hormone action.
Mechanisms of age-related changes in thyroid hormone action Although thyroid hormone action is mediated through its interaction with various cellular components (35, (42) (43) (44) , its major site of action is at specific nuclear receptors (65 (73) or modestly increased (75) with age. Braverman et al. (72) found that the T4 binding capacity of TBG was higher and that of thyroxine-binding prealbumin (transthyretin) lower in older subjects. However, the free T4 concentrations measured by equilibrium dialysis do not change signi¬ ficantly with age (76, 77) . The T3 binding capacity of plasma proteins as determined by equilibrium dialysis techniques also is not altered in an aging rat model (78) .
It is now generally accepted that cellular transport of thyroid hormone is a carrier-mediated process (78) (79) (80) (81) (82) (83) (84) .
As a variety of carrier-mediated transport processes are altered with aging (85) (86) (87) (88) (89) (90) (78) . The subcellular distribution of T3 in the liver was deter¬ mined and free T3 concentrations in the nucleus, cytoplasm and plasma were estimated. Measurements of free T3 concentration gradients across the cellular and nuclear membranes indicated that the age-related deficit in T3 uptake occurs at the plasma membrane level (78) (Fig. 5) . The 3 (78) .
The tissue metabolism of thyroid hormone is an important determinant of thyroid hormone action. In general, the deiodination rate of T4 and T3 is reduced in older subjects and the T4 metabolism is diverted to T3 production with age (21, 91) . However, the age-related changes often are tissue-and species-specific. In rats, unlike humans, T4 degradation is increased by 50% with age (21, 92) . The activity of deiodinase is altered with age in a tissue-specific manner. Decreased hepatic 5'-deiodinase activity has been found in aged rats, while pituitary type II 5'-deiodinase activity is increased (93) . The comparing only three young rats with three aged rats, nuclear T3 binding in vivo was no different in the two age groups (24) . It is noteworthy that the decreased T3 nuclear binding in vivo has been reported in diabetes (94) , food restriction (95, 96) (67) . A transcription factor P-l binds to S14 DNA at nucleotides -310 to -288 and represses S14 gene transcription (101) . Another transcription factor, PS-1, binds to S14 DNA at nucleotides -63 to -48 and stimulates S14 gene transcription. Aging is associated with decreased levels of P-l (67) . These changes may contribute to the age-related increase in S14 expression (67) . Of interest is the fact that thyroid hormone treatment is associated with increased levels of both the enhancing PS-1 and the repressing P-l factors (101, 102) . Thus 
